CUBE vs IBIO · P/E 25, rev $1.07B vs rev $100.0K
CubeSmart (CUBE) versus iBio, Inc. Common Stock (IBIO) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. IBIO currently screens at market cap $13.4M.
Not investment advice. Open the CUBE and IBIO stock pages for the full models.
Not investment advice.